OverviewAfter the successful 2016 events 'Advanced Diagnostics' and 'Biomarkers India' SELECTBIO presents to you "Biosensors, Biomarkers & Diagnostics - From Research to Commercialization" in Bengaluru, India. This conference will bring together scientists to discuss advancements in biosensors, biomarkers and other molecular approaches involved in the prognosis and diagnosis of diseases and leading to development of a novel diagnostic test.
The conference will broadly cover talks on novel biosensors and biomarkers, molecular pathway involved in the pathophysiology of the disease, prenatal diagnostic tests, macromolecule analysis, screening for infectious diseases, cytogenetic profiling, bio-imaging as well as molecular and companion diagnostics. We aim to focus on strategies to carry on the biomarker research up to commercial medical diagnostic product.
Who Should Attend
Scientists from the fields of Medicine, Pathology, Pharmaceutical sciences, Biotechnology and Diagnostics and will include scientists from medical colleges, pharma, biotech and diagnostic companies, leading universities and clinical research institutions, government and national research labs, CROs, emerging companies and tool providers working in the field of Biosensors, Biomarkers and Medical Diagnostics. This conference aims to provide scientists from the above fields a common meeting place to share their experiences and promote collaborations across industry and academia.
Venue and Date: Hotel Le Meridian, Bengaluru, May 25-26, 2017
International Advisory Board Members
Dr Janusz Rak, Professor, McGill University, Canada
Dr Matthew Marton, Director, Companion Diagnostics & Genomics, Merck, USA
Dr Panagiotis Karanis, Professor, University of Cologne, Germany
Dr Stephen Pennington, Professor, University College Dublin, Ireland
Sponsorship Options: Companies willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.